CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines

CHAPPER healthcare, AscellaHealth’s global pharmaceutical wholesaler, distributor and commercialization service provider, announces its appointment as president of EUROPACCESS, a strategic joint venture of seven pharmaceutical service providers across Europe. Offering integrated, commercialization and market access solutions to help navigate the complex healthcare systems throughout Europe, EUROPACCESS draws upon the leadership role of CHAPPER healthcare and its 50-year legacy of dedication to helping manufacturers improve patient outcomes by enhancing access to innovative therapies.

“For over five decades, CHAPPER healthcare has been bridging supply gaps and delivering medicines where they are needed most,” says Jonathan Chapper, CEO of CHAPPER healthcare. “Leading EUROPACCESS allows us to expand our mission to meet the growing needs of the specialty pharmaceutical supply chain across Europe, ultimately benefiting patients and healthcare providers.” 

Founded in 1975 by pharmacist Philip Chapper, CHAPPER healthcare has grown into a trusted partner for pharmaceutical manufacturers, wholesalers and healthcare providers across more than 75 countries. The company specializes in sourcing and supplying unlicensed and hard-to-access medicines, managing shortages and supporting early access and named patient programs. With MHRA-licensed warehouses in the UK and additional facilities in Germany, Ireland and the United States, CHAPPER healthcare delivers fully compliant, temperature-controlled supply chain logistics with speed and reliability.

EUROPACCESS, led by CHAPPER healthcare, is a dynamic alliance comprising leading pharmaceutical service providers across Europe:

  • CHAPPER healthcare (United Kingdom)
  • EURAXI (France)
  • Intsel Chimos (France)
  • ILAPO (Germany)
  • TETRAGO (Italy)
  • LENIS (Slovenia)
  • PHARMA INTERNATIONAL (Spain)

Together, these seven partners collectively provide life sciences stakeholders with a seamless market entry into more than 30 European healthcare systems and distribution networks, reaching over 6,000 hospitals. This extensive network leverages deep local expertise to accelerate market access and ensure adherence to regulatory standards.

Through its integrated network, EUROPACCESS offers a full suite of services tailored to support pharmaceutical product launches, distribution and lifecycle management. These services include:

  • Dossier submission and regulatory filings
  • Quality assurance and pharmacovigilance
  • Temperature-controlled storage and logistics
  • Reporting to national health authorities
  • Product launch and market access strategy
  • Localised sales, marketing and medical science liaison support
  • Data collection and analysis for outcomes reporting

“Our leadership in EUROPACCESS reflects our commitment to providing not just service capabilities but also meeting the needs of patients and their support systems,” adds Chapper. “Together, we are building a resilient, responsive and personalized pharmaceutical distribution model that delivers real impact.”

As AscellaHealth’s global pharmaceutical wholesaler, distributor and commercialization service provider, CHAPPER healthcare plays a vital role in advancing a comprehensive strategy to improve access to specialty and rare disease therapies worldwide. Through its leadership in EUROPACCESS, AscellaHealth further strengthens its European presence by leveraging CHAPPER’s local expertise and trusted distribution infrastructure.

Assuming leadership of EUROPACCESS marks a significant milestone for AscellaHealthTogether, we are committed to transforming pharmaceutical access across Europe with timely, secure and patient-centric solutions.”

Bill Oldham, chairman and president, AscellaHealth

Extending a strong commitment to advancing patient access to treatment and reinforcing global leadership in pharmaceutical distribution and specialty pharmacy services – including the role as president of EUROPACCESS, CHAPPER healthcare will participate in key industry events throughout the year. Join our team at the upcoming expopharm in Düsseldorf, 16–18 September 2025, at the CHAPPER healthcare booth located in Hall 3, Stand 3E75. To arrange a 1:1 meeting during the event, please contact John Burton – [email protected].

Posted in:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AscellaHealth, LLC.. (2025, September 16). CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines. News-Medical. Retrieved on September 16, 2025 from https://www.news-medical.net/news/20250916/CHAPPER-healthcare-AscellaHealthe28099s-global-pharmaceutical-distributor-assumes-presidency-of-EUROPACCESS-enhancing-access-to-innovative-medicines.aspx.

  • MLA

    AscellaHealth, LLC.. "CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines". News-Medical. 16 September 2025. <https://www.news-medical.net/news/20250916/CHAPPER-healthcare-AscellaHealthe28099s-global-pharmaceutical-distributor-assumes-presidency-of-EUROPACCESS-enhancing-access-to-innovative-medicines.aspx>.

  • Chicago

    AscellaHealth, LLC.. "CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines". News-Medical. https://www.news-medical.net/news/20250916/CHAPPER-healthcare-AscellaHealthe28099s-global-pharmaceutical-distributor-assumes-presidency-of-EUROPACCESS-enhancing-access-to-innovative-medicines.aspx. (accessed September 16, 2025).

  • Harvard

    AscellaHealth, LLC.. 2025. CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines. News-Medical, viewed 16 September 2025, https://www.news-medical.net/news/20250916/CHAPPER-healthcare-AscellaHealthe28099s-global-pharmaceutical-distributor-assumes-presidency-of-EUROPACCESS-enhancing-access-to-innovative-medicines.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.